Crystal structure and conformational analysis of ampullosporin A

Journal of Peptide Science

Volumn 9, Issue 11-12, 2003, Pages 729-744

  Kronen, Matthias ^a   Görls, Helmar ^b   Nguyen, Hoai Huong ^b   Reißmann, Siegmund ^b   Bohl, Martin ^c,d   Sühnel, Jürgen ^c   Gräfe, Udo ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d Tripos GmbH   (Germany)

Author keywords

Ampullosporin A; Bending analysis; Conformational analysis; Crystal structure; Ion channel; Molecular dynamics; Peptaibol

Indexed keywords

ALAMETHICIN; AMPULLOSPORIN A; ANTIAMEBIC AGENT; ANTIBIOTIC AGENT; CURVED DNA; HYDROXYPROLINE; ION CHANNEL; PEPTAIBOL; PROLINE; PROTEIN SUBUNIT; TRICHOTOXIN; UNCLASSIFIED DRUG; ZERVAMICIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; FUNGAL STRAIN; GEOMETRY; HYPOTHERMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPEDONIUM AMPULLOSPORUM; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; FUNGAL PROTEINS; ION CHANNELS; IONOPHORES; PEPTIDES; PROTEIN CONFORMATION; SOLVENTS;

FUNGI; PHOMA; PHOMA DESTRUCTIVA;

EID: 0344307483     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.495     Document Type: Article

References (39)

1. Chugh JK, Wallace BA. Peptaibols: models for ion channels. Biochem. Soc. Trans. 2001; 29: 565-570.
2. Fox RO, Richards FM. A voltage-gated ion channel model inferred from the crystal structure of alamethicin at 1.5 Å resolution. Nature 1982; 300: 325-330.
3. Snook CF, Woolley GA, Oliva G, Pattabhi V, Wood SF, Blundell TL, Wallace BA. The structure and function of antiamoebin I, a proline-rich membrane-active polypeptide. Structure 1998; 6: 783-792.
4. Karle IL, Perozzo MA, Mishra VK, Balaram P. Crystal structure of the channel-forming polypeptide antiamoebin in a membrane-mimetic environment. Proc. Natl Acad. Sci. USA 1998; 95: 5501-5504.
5. Anders R, Ohlenschlager O, Soskic V, Wenschuh H, Heise B, Brown LR. The NMR solution structure of the ion channel peptaibol chrysospermin C bound to dodecylphosphocholine micelles. Eur. J. Biochem. 2000; 267: 1784-1794.
6. Chugh JK, Bruckner H, Wallace BA. Model for a helical bundle channel based on the high-resolution crystal structure of trichotoxin0E. Biochemistry 2002; 41: 12934-12941.
7. Balashova TA, Shenkarev ZO, Tagaev AA, Ovchinnikova TV, Raap J, Arseniev AS. NMR structure of the channel-former zervamicin IIB in isotropic solvents. FEBS Lett. 2000; 466: 333-336.
8. Shenkarev ZO, Balashova TA, Efremov RG, Yakimenko ZA, Ovchinnikova TV, Raap J, Arseniev AS. Spatial structure of zervamicin IIB bound to DPC micelles: implications for voltage-gating. Biophys. J. 2002; 82: 762-771.
9. 1]zervamicin, a membrane ion-channel peptide: implications for gating mechanisms. Proc. Natl Acad. Sci. USA 1991; 88: 5307-5311.
10. Galbraith TP, Harris R, Driscoll PC, Wallace BA. Solution NMR studies of antiamoebin, a membrane channel-forming polypeptide. Biophys. J. 2003; 84: 185-194.
11. Toniolo C, Peggion C, Crisma M, Formaggio F, Shui X, Eggleston DS. Structure determination of racemic trichogin A IV using centrosymmetric crystals. Nat. Struct. Biol. 1994; 1: 908-914.
12. Condamine E, Rebuffat S, Prigent Y, Segalas I, Bodo B, Davoust D. Three-dimensional structure of the ion-channel forming peptide trichorzianin TA VII bound to sodium dodecyl sulfate micelles. Biopolymers 1998; 46: 75-88.
13. Ritzau M, Heinze S, Dornberger K, Berg A, Fleck W, Schlegel B, Härtl A, Gräfe U. Ampullosporin, a new peptaibol-type antibiotic from Sepedonium ampullosporum, HKI-0053 with neuroleptic activity in mice. J. Antibiol. (Tokyo) 1997; 50: 722-728.
14. Grigoriev PA, Berg A, Schlegel R, Gräfe U. Differences in ion permeability of an artificial bilayer membrane caused by ampullosporin and bergofungin, new 15-membered peptaibol-type antibiotics. Bioelectrochem. Bioenerg. 1997; 44: 155-158.
15. Kronen M, Kleinwachter P, Schlegel B, Härtl A, Gräfe U. Ampullosporines B,C,D,E1,E2,E3 and E4 from Sepedonium ampullosporum HKI-0053: Structures and biological activities. J. Antibiot. (Tokyo). 2001; 54: 17 517-17 518.
16. Grigoriev PA, Kronen M, Schlegel B, Härtl A, Gräfe U. Differences in ion-channel formation by ampullosporins B, C, D and semisynthetic desacetyltryptophanyl ampullosporin A. Bioelectrochemistry 2002; 57: 119-121.
17. Nguyen HH, Imhof D, Kronen M, Schlegel B, Härtl A, Gräfe U, Gera L, Reissmann S. Synthesis and biological evaluation of analogues of the peptaibol ampullosporin A. J. Med. Chem. 2002; 45: 2781-2787.
18. Grigoriev PA, Schlegel B, Kronen M, Berg A, Härtl A, Gräfe U. Differences in membrane pore formation by peptaibols. J. Peptide. Sci. 2003; 9: 763-768.
19. COLLECT, Data Collection Software; Nonius B.V., Netherlands, 1998.
20. Otwinowski Z, Minor W. Processing of x-ray diffraction data collected in oscillation mode. In Methods in Enzymology, Vol. 276. Macromolecular Crystallography, Part A. Carter CW, Sweet RM (eds). Academic Press: San Diego, 1997; 307-326.
21. Sheldrick GM. Phase annealing in SHELX-90: Direct methods for larger structures. Acta Crystallogr. Sect. A 1990; 46: 467-473.
22. Sheldrick GM. SHELXL-97, University of Göttingen, Germany, 1997.
23. Sklenar H, Etchebest C, Lavery R. Describing protein structure: a general algorithm yielding complete helicoidal parameters and a unique overall axis. Proteins 1989; 6: 46-60.
24. SYBYL Software: Tripos Inc., 1699; South Hanley Road, St. Louis, Missouri 63144, USA (www.tripos.com). SYBYL® is a Registered Trademark of Tripos, Inc.
25. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta Jr S, Weiner P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 1984; 106: 765-784.
26. Weiner SJ, Kollman PA, Nguyen DT, Case DA. An all atom force field for simulations of proteins and nucleic acids. J. Comp. Chem. 1986; 7: 230-252.
27. Krause K, Pineda LF, Peteranderl R, Reissmann S. Conformational properties of a cyclic peptide bradykinin B2 receptor antagonist using experimental and theoretical methods J. Peptide Res. 2000; 55: 63-71.
28. De Groot BL, Daura X, Mark AE, Grubmüller H. Essential dynamics of reversible peptide folding: memory-free conformational dynamics governed by internal hydrogen bonds. J. Mol. Biol. 2001; 309: 299-313.
29. 10-helix. Trends Biochem. Sci. 1991; 16: 350-353.
30. Hutchinson EG, Thornton JM. PROMOTIF - a program to identify and analyze structural motifs in proteins. Protein Sci. 1996; 5: 212-220.
31. 10-helices. Angew. Chem. 1987; 26: 1150-1152.
32. Karle I, Balaram P. Structural characteristics of alpha-helical peptide molecules containing Aib residues. Biochemistry 1990; 29: 6747-6756.
33. 10-Helix versus α-helix: a molecular dynamics study of conformational preferences of Aib and alanine. J. Am. Chem. Soc. 1994; 116: 11 915-11 921.
34. Tieleman DP, Sansom MS, Berendsen HJ. Alamethicin helices in a bilayer and in solution: molecular dynamics simulations. Biophys. J. 1999; 76: 40-49.
35. Sansom MS. Alamethicin and related peptaibols - model ion channels. Eur. Biophys. J. 1993; 22: 105-124.
36. Menestrina G, Voges KP, Jung G, Boheim G. Voltage-dependent channel formation by rods of helical polypeptides. J. Membr. Biol. 1986; 93: 111-132.
37. Rizzo V, Schwarz G, Voges KP, Jung G. Molecular shape and dipole moment of alamethicin-like synthetic peptides. Eur. J. Biophys. 1985; 12: 67-73.
38. Wu Y, He K, Ludtke SJ, Huang HW. X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytainol phosphatidylchooline with alamethicin at low concentrations. Biophys. J. 1995; 68: 2361-3269.
39. Cascio M, Wallace BA. Conformation of alamethicin in phospholipid vesicles: implications for insertion models. Proteins 1988; 4: 89-98.